Discovery and development of safe-in-man broad-spectrum antiviral agents
Viral diseases are one of the leading causes of morbidity and mortality in the world. Virus-specific vaccines and antiviral drugs are the most powerful tools to combat viral diseases. However, broad-spectrum antiviral agents (BSAAs, i.e. compounds targeting viruses belonging to two or more viral fam...
Main Authors: | Petter I. Andersen, Aleksandr Ianevski, Hilde Lysvand, Astra Vitkauskiene, Valentyn Oksenych, Magnar Bjørås, Kaidi Telling, Irja Lutsar, Uga Dumpis, Yasuhiko Irie, Tanel Tenson, Anu Kantele, Denis E. Kainov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S120197122030076X |
Similar Items
-
Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study
by: Aleksandr Ianevski, et al.
Published: (2021-08-01) -
Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
by: Aleksandr Ianevski, et al.
Published: (2021-09-01) -
Low Temperature and Low UV Indexes Correlated with Peaks of Influenza Virus Activity in Northern Europe during 2010–2018
by: Aleksandr Ianevski, et al.
Published: (2019-03-01) -
Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
by: Kaidi Telling, et al.
Published: (2018-10-01) -
Identification and Tracking of Antiviral Drug Combinations
by: Aleksandr Ianevski, et al.
Published: (2020-10-01)